BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15551573)

  • 1. Absorbed doses for internal radiotherapy from 22 beta-emitting radionuclides: beta dosimetry of small spheres.
    Bardiès M; Chatal JF
    Phys Med Biol; 1994 Jun; 39(6):961-81. PubMed ID: 15551573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo dose voxel kernel calculations of beta-emitting and Auger-emitting radionuclides for internal dosimetry: A comparison between EGSnrcMP and EGS4.
    Strigari L; Menghi E; D'Andrea M; Benassi M
    Med Phys; 2006 Sep; 33(9):3383-9. PubMed ID: 17022234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric characterization of radionuclides for systemic tumor therapy: influence of particle range, photon emission, and subcellular distribution.
    Uusijärvi H; Bernhardt P; Ericsson T; Forssell-Aronsson E
    Med Phys; 2006 Sep; 33(9):3260-9. PubMed ID: 17022220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calculation of electron and isotopes dose point kernels with FLUKA Monte Carlo code for dosimetry in nuclear medicine therapy.
    Botta F; Mairani A; Battistoni G; Cremonesi M; Di Dia A; Fassò A; Ferrari A; Ferrari M; Paganelli G; Pedroli G; Valente M
    Med Phys; 2011 Jul; 38(7):3944-54. PubMed ID: 21858991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences among Monte Carlo codes in the calculations of voxel S values for radionuclide targeted therapy and analysis of their impact on absorbed dose evaluations.
    Pacilio M; Lanconelli N; Lo MS; Betti M; Montani L; Torres AL; Coca PM
    Med Phys; 2009 May; 36(5):1543-52. PubMed ID: 19544770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the EGS usercode DOSE3D for internal beta dose calculation at the cellular and tissue levels.
    Coulot J; Ricard M; Aubert B
    Phys Med Biol; 2003 Aug; 48(16):2591-602. PubMed ID: 12974576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorbed fractions in ellipsoidal volumes for beta(-) radionuclides employed in internal radiotherapy.
    Amato E; Lizio D; Baldari S
    Phys Med Biol; 2009 Jul; 54(13):4171-80. PubMed ID: 19521004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrete beta dose kernel matrices for nuclides applied in targeted radionuclide therapy (TRT) calculated with MCNP5.
    Reiner D; Blaickner M; Rattay F
    Med Phys; 2009 Nov; 36(11):4890-6. PubMed ID: 19994497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose per unit cumulated activity (S-values) for e⁻ and beta emitting radionuclides in cancer cell models calculated by Monte Carlo simulation.
    Rojas-Calderón EL; Torres-García E; Ávila O
    Appl Radiat Isot; 2014 Aug; 90():229-33. PubMed ID: 24814610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of radiation dose at various depths for commonly used radionuclides in radiosynoviorthesis in a tissue equivalent material.
    Tandon P; Malpani BL; Venkatesh M; Bhatt BC
    Med Phys; 2006 Aug; 33(8):2744-50. PubMed ID: 16964849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-tumor radionuclide therapy dosimetry: new paradigms in view of tumor microenvironment and angiogenesis.
    Zhu X; Palmer MR; Makrigiorgos GM; Kassis AI
    Med Phys; 2010 Jun; 37(6):2974-84. PubMed ID: 20632610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor dosimetry in radioimmunotherapy: methods of calculation for beta particles.
    Leichner PK; Kwok CS
    Med Phys; 1993; 20(2 Pt 2):529-34. PubMed ID: 8492761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accounting for beta-particle energy loss to cortical bone via paired-image radiation transport (PIRT).
    Shah AP; Rajon DA; Patton PW; Jokisch DW; Bolch WE
    Med Phys; 2005 May; 32(5):1354-66. PubMed ID: 15984687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brachytherapy dosimetry parameters calculated for a new 103Pd source.
    Rivard MJ; Melhus CS; Kirk BL
    Med Phys; 2004 Sep; 31(9):2466-70. PubMed ID: 15487726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theoretical study of the influence of a heterogeneous activity distribution on intratumoral absorbed dose distribution.
    Bao A; Zhao X; Phillips WT; Woolley FR; Otto RA; Goins B; Hevezi JM
    Med Phys; 2005 Jan; 32(1):200-8. PubMed ID: 15719971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phantom size in brachytherapy source dosimetric studies.
    Pérez-Calatayud J; Granero D; Ballester F
    Med Phys; 2004 Jul; 31(7):2075-81. PubMed ID: 15305460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow dosimetry using blood-based models for radiolabeled antibody therapy: a multiinstitutional comparison.
    Wessels BW; Bolch WE; Bouchet LG; Breitz HB; Denardo GL; Meredith RF; Stabin MG; Sgouros G;
    J Nucl Med; 2004 Oct; 45(10):1725-33. PubMed ID: 15471841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetry of beta nuclide filled balloon catheter in endovascular brachytherapy.
    Chen Y; Geng J; Tian J; Yin D; Chen S
    Biomed Mater Eng; 2004; 14(3):337-9. PubMed ID: 15299246
    [No Abstract]   [Full Text] [Related]  

  • 19. Transfer standard for beta decay radionuclides in radiotherapy.
    Thieme K; Beinlich U; Fritz E
    Appl Radiat Isot; 2004; 60(2-4):519-22. PubMed ID: 14987695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimates of beta absorbed fractions in small tissue volumes for selected radionuclides.
    Akabani G; Poston JW; Bolch WE
    J Nucl Med; 1991 May; 32(5):835-9. PubMed ID: 2022992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.